C07C 239/08
Hydroxylamino compounds or their ethers or esters
C07C239/08 (Hydroxylamino compounds or their ethers or esters) appears on 379 US grants and 246 published applications in this corpus.
Search patents in C07C- Granted patents
- 379
- Published applications
- 246
- Assignees
- 217
- Inventors
- 1,004
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 13 | 0 |
| 1992 | 21 | 0 |
| 1993 | 10 | 0 |
| 1994 | 14 | 0 |
| 1995 | 16 | 0 |
| 1996 | 23 | 0 |
| 1997 | 35 | 0 |
| 1998 | 15 | 0 |
| 1999 | 7 | 0 |
| 2000 | 13 | 0 |
| 2001 | 15 | 1 |
| 2002 | 10 | 14 |
| 2003 | 16 | 18 |
| 2004 | 12 | 10 |
| 2005 | 8 | 15 |
| 2006 | 5 | 12 |
| 2007 | 9 | 15 |
| 2008 | 7 | 10 |
| 2009 | 5 | 8 |
| 2010 | 8 | 11 |
| 2011 | 6 | 12 |
| 2012 | 6 | 4 |
| 2013 | 9 | 6 |
| 2014 | 4 | 10 |
| 2015 | 9 | 10 |
| 2016 | 12 | 18 |
| 2017 | 10 | 10 |
| 2018 | 10 | 8 |
| 2019 | 4 | 9 |
| 2020 | 2 | 9 |
| 2021 | 7 | 10 |
| 2022 | 7 | 3 |
| 2023 | 4 | 8 |
| 2024 | 3 | 5 |
| 2025 | 4 | 5 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 239/20Having oxygen atoms of hydroxylamino groups etherified211
- C07C 239/10Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of86
- C07C 239/18Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of83
- C07C 239/12Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of28
- C07C 239/22Having oxygen atoms of hydroxylamino groups esterified22
- C07C 239/16Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of21
- C07C 239/14Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of17
Recent patents
- Acyclic lipids and methods of use thereof10 Feb 2026US 12,545,636 B2ReNAgade Therapeutics Management Inc.
- GPX4 inhibitors, pharmaceutical compositions thereof, and their use for treating GPX4-mediated diseases6 Jan 2026US 12,516,016 B2Eubulus Biotherapeutics (Hong Kong) Limited
- Enantioselective process30 Dec 2025US 12,509,417 B2Syngenta Crop Protection AG
- Hydrogenation process of oxime derivatives9 Dec 2025US 12,491,503 B2Syngenta Crop Protection AG
- Process for the purification of a mixture comprising N-alkyl-hydroxylammonium salts26 Aug 2025US 12,398,091 B2BASF SE
- Fluorinated compound, photopolymerizable composition, hologram recording medium, preparation method thereof and optical element comprising the same3 Sep 2026US 2026/0259528 A1LG Chem.Ltd.
- Phenoxycarbamoyl chloride compound and method for producing same16 Jul 2026US 2026/0200839 A1Nippon Soda Co., Ltd.
- Enamine n-oxide tools for target identification applications25 Jun 2026US 2026/0176274 A1Dana-Farber Cancer Institute, Inc.
- Aminoindane Compounds and Compositions and Methods of Their Therapeutic Use11 Jun 2026US 2026/0159474 A1Solvonis Therapeutics Ireland Holdings Limited
- (2,4-dichlorophenoxy)acetic acid analogs12 Feb 2026US 2026/0042731 A1Corteva Agriscience LLC
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds149US 5,965,434 A1999
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996
- 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors87US 6,310,060 B1Warner-Lambert Company · 2001